Standard BioTools: Adam Taich, Shane Brown, Tom Carey, Troy Cox, Cathy Hibbs, Carlos Paya, Laura Clague, Martin Madaus
Following the completion of Standard BioTools' merger with SomaLogic, the company has appointed Adam Taich, SomaLogic's interim CEO, as chief strategy officer and Shane Bowen, SomaLogic's chief R&D officer, as chief technology officer. Further, the firm added former SomaLogic board members Tom Carey, Troy Cox, and Kathy Hibbs to its board of directors, where Carey will serve as chairman. Meanwhile, Carlos Paya, Laura Clague, and Martin Madaus have resigned from Standard BioTools' board.